COST NO FEENO SET ASIDE USED.

THE CRITICAL PATH INSTITUTE - BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING

PIID: 75F40119C10135Solicitation ID: FDABAA1900123

Signed Date: Oct 30, 2025Effective Date: Sep 30, 2019End Date: Closed on Sep 29, 2025

Award $

$2.7M

Vendor

THE CRITICAL PATH INSTITUTE

NAICS

541715

Signed Date

Oct 30, 2025

Key Details

Dollars Obligated

$2.7M

Base & All Options

$-18,014.41

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

Food and Drug Administration

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Product Service Code

AZ12 - R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

TUCSON, AZ, 857185893, CD-AZ-06

Description

BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING

Context & Analysis

On Oct 30, 2025, Department of Health and Human Services obligated $2,739,756.59 to THE CRITICAL PATH INSTITUTE for broad agency announcement (baa) contract -- developing novel clinical outcome assessments for pediatric asthma to facilitate innovative patient-focused drug development and aid regulatory decision mak…. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 12 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in TUCSON, AZ.